Intravenous Artesunate for Severe Malaria in Travelers, Europe.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      Multicenter trials in Southeast Asia have shown better survival rates among patients with severe malaria, particularly those with high parasitemia levels, treated with intravenous (IV) artesunate than among those treated with quinine. In Europe, quinine is still the primary treatment for severe malaria. We conducted a retrospective analysis for 25 travelers with severe malaria who returned from malaria-endemic regions and were treated at 7 centers in Europe. All patients survived. Treatment with IV artesunate rapidly reduced parasitemia levels. In 6 patients at 5 treatment centers, a self-limiting episode of unexplained hemolysis occurred after reduction of parasitemia levels. Five patients required a blood transfusion. Patients with posttreatment hemolysis had received higher doses of IV artesunate than patients without hemolysis. IV artesunate was an effective alternative to quinine for treatment of malaria patients in Europe. Patients should be monitored for signs of hemolysis, especially after parasitologic cure. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
    • ISSN:
      1080-6040
    • Accession Number:
      10.3201/eid1705.101229
    • Accession Number:
      95750708
  • Citations
    • ABNT:
      ZOLLER, T. et al. Intravenous Artesunate for Severe Malaria in Travelers, Europe. Emerging Infectious Diseases, [s. l.], v. 17, n. 5, p. 771, 2011. DOI 10.3201/eid1705.101229. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=f5h&AN=95750708. Acesso em: 29 mar. 2020.
    • AMA:
      Zoller T, Junghanss T, Kapaun A, et al. Intravenous Artesunate for Severe Malaria in Travelers, Europe. Emerging Infectious Diseases. 2011;17(5):771. doi:10.3201/eid1705.101229.
    • APA:
      Zoller, T., Junghanss, T., Kapaun, A., Gjørup, I., Richter, J., Hugo-Persson, M., Mørch, K., Foroutan, B., Suttorp, N., Yürek, S., & Flick, H. (2011). Intravenous Artesunate for Severe Malaria in Travelers, Europe. Emerging Infectious Diseases, 17(5), 771. https://doi.org/10.3201/eid1705.101229
    • Chicago/Turabian: Author-Date:
      Zoller, Thomas, Thomas Junghanss, Annette Kapaun, Ida Gjørup, Joachim Richter, Mats Hugo-Persson, Kristine Mørch, et al. 2011. “Intravenous Artesunate for Severe Malaria in Travelers, Europe.” Emerging Infectious Diseases 17 (5): 771. doi:10.3201/eid1705.101229.
    • Harvard:
      Zoller, T. et al. (2011) ‘Intravenous Artesunate for Severe Malaria in Travelers, Europe’, Emerging Infectious Diseases, 17(5), p. 771. doi: 10.3201/eid1705.101229.
    • Harvard: Australian:
      Zoller, T, Junghanss, T, Kapaun, A, Gjørup, I, Richter, J, Hugo-Persson, M, Mørch, K, Foroutan, B, Suttorp, N, Yürek, S & Flick, H 2011, ‘Intravenous Artesunate for Severe Malaria in Travelers, Europe’, Emerging Infectious Diseases, vol. 17, no. 5, p. 771, viewed 29 March 2020, .
    • MLA:
      Zoller, Thomas, et al. “Intravenous Artesunate for Severe Malaria in Travelers, Europe.” Emerging Infectious Diseases, vol. 17, no. 5, May 2011, p. 771. EBSCOhost, doi:10.3201/eid1705.101229.
    • Chicago/Turabian: Humanities:
      Zoller, Thomas, Thomas Junghanss, Annette Kapaun, Ida Gjørup, Joachim Richter, Mats Hugo-Persson, Kristine Mørch, et al. “Intravenous Artesunate for Severe Malaria in Travelers, Europe.” Emerging Infectious Diseases 17, no. 5 (May 2011): 771. doi:10.3201/eid1705.101229.
    • Vancouver/ICMJE:
      Zoller T, Junghanss T, Kapaun A, Gjørup I, Richter J, Hugo-Persson M, et al. Intravenous Artesunate for Severe Malaria in Travelers, Europe. Emerging Infectious Diseases [Internet]. 2011 May [cited 2020 Mar 29];17(5):771. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=f5h&AN=95750708